|
Variables
|
Before
|
6 months
|
|---|
|
Systolic blood pressure (mmHg)
|
156.6 ± 3.4
|
155.0 ± 2.9
|
|
Diastolic blood pressure (mmHg)
|
76.6 ± 3.2
|
73.4 ± 2.9
|
|
Antihypertensive medication
| | |
|
Diuretics (%)
|
23.8
|
19.0
|
|
α-blocker (%)
|
4.8
|
4.8
|
|
β-blocker (%)
|
23.8
|
23.8
|
|
Calcium antagonist (%)
|
42.9
|
42.9
|
|
Angiotensin II type 1 receptor blocker (%)
|
47.6
|
52.4
|
|
M-mode echocardiography
| | |
|
EF (%)
|
69.1 ± 10.8
|
69.8 ± 10.5
|
|
FS (%)
|
42.2 ± 11.4
|
46.1 ± 9.8**
|
|
LVDd (cm)
|
4.5 ± 0.9
|
4.6 ± 0.8
|
|
LVDs (cm)
|
2.6 ± 0.9
|
2.5 ± 0.8
|
|
IVS (mm)
|
14 ± 3
|
15 ± 3
|
|
LVPW (cm)
|
1.4 ± 0.2
|
1.3 ± 0.3
|
|
LVM (g)
|
308.2 ± 131.1
|
303.5 ± 104.4
|
|
LVMI (g/m2)
|
217.8 ± 100.2
|
212.3 ± 77.3
|
|
Chest X-ray
| | |
|
CTR (%)
|
52.8 ± 5.3
|
52.4 ± 5.0
|
|
Laboratory data
| | |
|
BNP (pg/mL)
|
621.4 ± 666.8
|
412.0 ± 426.0*
|
-
EF ejection fraction, FS fractional shortening, LVDd left ventricular end-diastolic dimension, LVDs left ventricular end-systolic dimension, IVS interventricular septal thickness, LVPW left ventricular posterior wall end-diastolic thickness, LVFS left ventricular fractional shortening, LVM left ventricular mass, LVMI left ventricular mass index, CTR cardiothoracic ratio, BNP: brain natriuretic peptide, SD standard deviation
- *p < 0.05, **p < 0.01 vs. before treatment. Data, means ± SD
